These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1504394)

  • 21. Using data from automated dispensing units to identify adverse drug reactions.
    McIntosh ST; Petropoulos JB
    Am J Health Syst Pharm; 2005 Nov; 62(22):2397-400. PubMed ID: 16278332
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of a Community Pharmacy-Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems.
    Pammett RT; Blackburn D; Taylor J; Mansell K; Kwan D; Papoushek C; Jorgenson D
    Pharmacotherapy; 2015 Sep; 35(9):881-6. PubMed ID: 26406776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computerized surveillance for adverse drug events in a pediatric hospital.
    Kilbridge PM; Noirot LA; Reichley RM; Heard KM; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2008 Nov; ():1004. PubMed ID: 18998917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.
    De Bruin ML; van Puijenbroek EP; Bracke M; Hoes AW; Leufkens HG
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):99-105. PubMed ID: 16329159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse drug reactions.
    Shuttleworth A
    Nurs Times; 2006 Jul 25-31; 102(30):58. PubMed ID: 16903313
    [No Abstract]   [Full Text] [Related]  

  • 26. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
    Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
    Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India.
    Chatterjee S; Lyle N; Ghosh S
    Drug Saf; 2006; 29(7):641-2. PubMed ID: 16808556
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dealing with adverse drug reactions in dentistry. Procedures on encountering adverse drug reactions and goal of the Swiss Pharmacovigilance system].
    Egger SS; Krähenbühl S; Schlienger RG
    Schweiz Monatsschr Zahnmed; 2005; 115(12):1209-18. PubMed ID: 16408825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety monitoring of new anti-malarials in immediate post-marketing phase.
    Edwards IR
    Med Trop (Mars); 1998; 58(3 Suppl):93-6. PubMed ID: 10212911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A standards-based clinical information system for HIV/AIDS.
    Stitt FW
    Medinfo; 1995; 8 Pt 1():402. PubMed ID: 8591210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of adverse drug reactions with the use of a simple questionnaire].
    Tsuchiya H; Shiragami M
    Yakugaku Zasshi; 2010 Sep; 130(9):1233-7. PubMed ID: 20823681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association.
    Marcocci C; Watt T; Altea MA; Rasmussen AK; Feldt-Rasmussen U; Orgiazzi J; Bartalena L;
    Eur J Endocrinol; 2012 Feb; 166(2):247-53. PubMed ID: 22058081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Patient-reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL): A novel instrument for medication management.
    Sakthong P; Suksanga P; Sakulbumrungsil R; Winit-Watjana W
    Res Social Adm Pharm; 2015; 11(3):315-38. PubMed ID: 25453539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A portable database of adverse reactions and drug interactions with radiopharmaceuticals.
    Gómez Perales JL; Martínez AA
    J Nucl Med Technol; 2013 Sep; 41(3):212-5. PubMed ID: 23857419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmarketing surveillance of adverse drug reactions: patient self-monitoring.
    Fisher S; Bryant SG
    J Am Board Fam Pract; 1992; 5(1):17-25. PubMed ID: 1561919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
    Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
    Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incidence and prevalence of adverse drug reactions].
    Haramburu F; Pouyanne P; Imbs JL; Blayac JP; Bégaud B
    Presse Med; 2000 Jan; 29(2):111-4. PubMed ID: 10682042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse drug reactions in neonates: could we be documenting more?
    Hawcutt DB; O'Connor O; Turner MA
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.